Akebia prevails over Fibrogen in UK patent suit

23-04-2020

Rory O'Neill

Akebia prevails over Fibrogen in UK patent suit

Chrispictures / shutterstock.com

Massachusetts-based pharmaceutical company Akebia has had five Fibrogen patents for an anaemia treatment invalidated at the English High Court.


Akebia, Fibrogen, patent, anaemia, vadadustat, HIF-PHIs, Arnold, English High Court, Hogan Lovells, Astellas, Potter Clarkson, Carpmaels and Ransford

LSIPR